AlphAIAlphAI — Financial news for AI agents
financial-news.co.ukSEP 92 min read$INNV

InnovAge shares jump 13% as fiscal 2027 guidance tops $1bn

InnovAge Holding Corp (INNV) reported fiscal 2026 results and fiscal 2027 guidance of $1.05bn to $1.085bn in revenue. Shares rose 13.12% to $11.90. Management reported a 175% increase in adjusted EBITDA, though GAAP net income showed volatility. The company plans to scale operations and expand value-based care. Three private-equity sponsors filed SEC forms around the earnings release.

Original reporting
financial-news.co.uk
Published Sep 9, 2026, 4:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 4:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
InnovAge shares jump 13% as fiscal 2027 guidance tops $1bn — source image
Source · financial-news.co.uk
Decision brief

The 30-second read

$INNVBullishHigh
01

Why it matters

The guidance beat and 13% price jump provide a clear short‑term trading catalyst; investors will monitor the first FY2027 quarter for execution.

02

Market read

The earnings release and upbeat guidance are the primary drivers of market reaction, making the article highly relevant for traders.

03

What to watch

Short‑sale volume increase suggests some traders are hedging against potential downside.

Relevance 9/10Novelty 9/10Timing: post‑earnings release day

Background

InnovAge Holding Corp (NASDAQ: INNV) disclosed Q4 2026 results and FY2027 guidance, with adjusted EBITDA up 175% YoY and revenue guidance above $1 bn.

Company-level read

Ticker impact

$INNVBullishHigh confidence
Context

InnovAge reported Q4 2026 results and FY2027 guidance of $1.05‑$1.085 bn, sending the stock up 13% on the day.

Expected impact

Potential further upside on follow‑through buying; watch for pull‑back if guidance is missed.

Evidence & confidence

Revenue guidance in the $1 bn range for a mid‑cap health‑tech firm is materially higher than prior guidance, and the 13% price jump indicates strong market interest.

Market effects

Sector

Higher guidance may lift other senior‑care and value‑based care providers.

Regional

Positive for U.S. health‑tech stocks in the short term.

Global

Limited to U.S. markets; no immediate global macro effect.

Counterpoint

What could challenge this read

If legal accruals recur, earnings could turn negative, making the stock vulnerable to a correction.

Key entities

  • company
    InnovAge Holding Corp

    U.S. listed senior‑care provider reporting earnings and guidance.

Read at source← All news

Related articles

SEP 10
$INNVMedAI 8/10

InnovAge Holding Corp. Q4 2026 Earnings Call Summary

InnovAge Holding Corp. completed 'InnovAge 2.0' in 2026, focusing on operational improvements. 'InnovAge 3.0' will prioritize scaling and expansion. For 2027, the company projects 1.5% to 2.0% net Medicare rate increases and revenue of $1.05B to $1.085B, with growth driven by enrollment and utilization management. Management prefers M&A over de novo centers for capital allocation.

yahoo.com3 min
SEP 9
$INNVHighAI 8/10

InnovAge (INNV) Q4 2026 Earnings Call Transcript

InnovAge (INNV) reported Q4 2026 revenue of $262.0M, up 18.3% YoY, and net income of $9.8M. Full-year revenue rose 15.9% to $989.7M, with adjusted EBITDA increasing 174.2% to $94.6M. The company guided FY 2027 revenue to $1.05B-$1.085B and adjusted EBITDA to $105M-$115M, citing census growth and rate increases. Management highlighted expansion plans and potential M&A activity, while noting risks from Medicaid rate uncertainties in key states.

fool.com3 min
SEP 9
$INNVHighAI 8/10

Why is InnovAge stock up 14% today?

InnovAge (INNV) stock rose 14.6% in pre-market trading after reporting fiscal Q4 and full-year 2026 results. Adjusted EBITDA increased 175% to $94.6M, revenue grew 15.9% to $989.7M, and net loss narrowed to $0.7M. The company issued fiscal 2027 guidance targeting revenue of $1.05B-$1.085B and adjusted EBITDA of $105M-$115M. CEO Patrick Blair highlighted a strategic focus on scaling through technology, AI, and potential acquisitions.

investing.com2 min
SEP 8
$INNVMedAI 9/10

InnovAge Q4 Earnings Call Highlights

InnovAge reported Q4 cost of care rose 16.1% to $312.1M. It held $97.9M in cash, $43.4M in short-term investments, and $63.3M in debt. The company projected fiscal 2027 revenue of $1.05B-$1.085B, adjusted EBITDA of $105M-$115M, and 5%-7.5% growth. It outlined 'InnovAge 3.0' strategy, focusing on scaling and acquisitions.

yahoo.com2 min